1MData (Beijing Yiming Technology Co., Ltd) is a leading player in the healthcare industry, backed by the China National Small and Medium Enterprise Development Fund. With 3 patents and software copyrights, they specialize in medical data services, including data interconnection, structurization, standardization, mining, and analysis. Their extensive reach covers 10,000,000+ Patient Case Library and data channels in 310+ hospitals across China. This startup aims to provide a real-world clinical data platform for pharmaceutical and medical device companies. They have agreements with Chinese Hospitals/Medical Associations for data processing and analysis eligibility, and copyrights of the reports. Notably, they have strategic partnerships with major medical organizations and have played a pivotal role in research on information standards related to China's National Health and Family Planning Commission. 1MData prioritizes data security and compliance with national/international standards and regulations, and is affiliated with prestigious organizations such as CDISC and HL7-China. Their latest $15.00M Series B investment in November 2017 from Shenzhen Guozhong Venture Capital Management underscores their impressive growth and potential in the healthcare data industry. Their unique position as the only Medical Big Data company selected for Microsoft Accelerator further underscores their position as an attractive investment opportunity.
No recent news or press coverage available for 1MData (Beijing Yiming Technology Co., Ltd).